CureSearch for Children’s Cancer, a national non-profit organization dedicated to accelerating the development of pediatric cancer treatments, has officially announced the launch of its 2026 CureSearch Community Impact Awards (CCIA). This initiative, made possible through a significant grant from Resonance Philanthropies, marks a strategic expansion of the organization’s mission. While CureSearch has historically focused on funding high-potential translational research to move laboratory discoveries into clinical settings, the CCIA represents a commitment to addressing the immediate, non-medical needs of children and families navigating the complexities of a cancer diagnosis.
The 2026 CCIA program is designed to provide financial resources to community-based programs and local hospital initiatives that offer emotional, psychological, and social support. By awarding grants of up to $15,000 to selected pediatric cancer centers and non-profit organizations, CureSearch aims to strengthen the safety net for families during one of the most challenging periods of their lives. These awards serve as a vital complement to the organization’s scientific research portfolios, including its Catapult, Acceleration Initiative, and Young Investigator grants, ensuring that progress in childhood cancer care is pursued on both a biological and a human level.
The Dual Mandate: Scientific Innovation and Holistic Care
The landscape of pediatric oncology is often defined by the search for "the cure," but for the approximately 15,000 children and adolescents diagnosed with cancer each year in the United States, the journey involves far more than chemotherapy and radiation. Pediatric cancer remains the leading cause of death by disease in children, yet the survival rate for many types of childhood cancer has climbed to over 80% due to decades of research. However, this increase in survival rates has brought to light the long-term psychosocial challenges faced by survivors and their families.
CureSearch’s decision to expand the CCIA program for the 2026 cycle reflects a growing consensus within the medical community that "caring for the child" must encompass the "whole child." Psychosocial support is no longer viewed as an optional luxury but as a clinical necessity. Studies have shown that children who receive comprehensive emotional and social support during treatment experience lower levels of distress, better adherence to treatment protocols, and improved long-term mental health outcomes. By funding programs that address these needs, CureSearch is targeting the "hidden" burden of cancer—the anxiety, isolation, and trauma that often persist long after a patient enters remission.
Strategic Partnership with Resonance Philanthropies
The expansion of the Community Impact Awards is fueled by a generous grant from Resonance Philanthropies, an organization known for its commitment to social impact and community resilience. This partnership underscores a collaborative approach to philanthropy, where large-scale research funding is paired with targeted, grassroots support.
The funding provided by Resonance Philanthropies allows CureSearch to reach deeper into local communities. While the organization’s research grants often go to large academic institutions and pharmaceutical collaborators to develop new drugs, the CCIA grants are intended for the frontline workers—the social workers, child life specialists, and community organizers who interact with families daily. This bifurcated strategy ensures that while CureSearch works toward the treatments of tomorrow, it is also alleviating the suffering of today.
Targeted Interventions: What the CCIA Funds
The 2026 CCIA recipients will utilize their grants to implement or expand a variety of evidence-based psychosocial programs. These initiatives are tailored to the unique developmental needs of children and the systemic needs of their families. Key areas of focus for the 2026 funding cycle include:
Therapeutic Play and Art Therapy
For a child, the hospital environment can be sterile and frightening. Art and play therapy provide a non-verbal outlet for children to express their fears and process their experiences. These programs, often led by certified child life specialists, help normalize the hospital environment and provide children with a sense of agency during a time when they have very little control over their bodies or schedules.
Support Groups and Peer Connection
A cancer diagnosis often leads to profound social isolation for both the patient and their siblings. CCIA-funded support groups provide a space for families to connect with others facing similar challenges. These connections are vital for reducing the "crisis of loneliness" that often accompanies long-term hospitalization and intensive treatment regimens.

Educational Resources and Workshops
Navigating the healthcare system requires a high level of health literacy. CCIA grants support the development of educational materials that help parents understand their child’s diagnosis, treatment options, and the potential long-term side effects of therapy. Workshops may also focus on financial literacy, helping families manage the significant economic strain of a pediatric cancer diagnosis.
Survivorship and Transition Services
As more children survive cancer, the transition from active treatment back to "normal" life—including returning to school—presents its own set of hurdles. Programs funded by the CCIA often assist in this transition, providing neuropsychological assessments and educational advocacy to ensure that survivors receive the support they need to thrive in a classroom setting.
Supporting the Frontlines: Institutional Impact
Among the primary beneficiaries of the CCIA program are pediatric cancer centers that serve as the hubs of care for their regions. Jennifer Roe Darling, President and CEO of the Children’s Hospital Colorado Foundation, emphasized the importance of such community-focused funding. "We are so thankful for our community of supporters like CureSearch," Darling stated. "Your generosity and spirit allow us to focus on what matters most: caring for children."
The Children’s Hospital Colorado is indicative of the type of institution the CCIA seeks to support—those that integrate high-level clinical care with a deep commitment to the family unit. By providing these institutions with flexible funding, CureSearch allows them to fill gaps in care that are often not covered by insurance or traditional research grants.
The Economic and Psychological Data Behind the Need
The necessity for the CCIA is supported by a growing body of data regarding the "financial toxicity" and psychological toll of pediatric cancer. According to research published in the Journal of Clinical Oncology, families of children with cancer face significant out-of-pocket costs, with many reporting a loss of more than 40% of their annual household income due to treatment-related expenses and lost work hours.
Furthermore, the psychological impact on the family system is profound. Approximately 25% of parents of children with cancer meet the criteria for Post-Traumatic Stress Disorder (PTSD), and siblings often experience "shadow grief," where their needs are sidelined by the medical crisis of their brother or sister. The CCIA-funded programs are specifically designed to mitigate these systemic shocks, providing a buffer that can prevent a medical crisis from becoming a permanent family catastrophe.
Chronology of the 2026 Award Cycle
The rollout of the 2026 CureSearch Community Impact Awards follows a structured timeline designed to identify the programs with the highest potential for immediate impact.
- Phase I: Application and Outreach: CureSearch initiated a call for proposals from pediatric hospitals and community organizations across the United States. The criteria focused on program sustainability, the evidence base for the proposed interventions, and the ability to reach underserved populations.
- Phase II: Review and Selection: A committee of experts in pediatric oncology and psychosocial care reviewed the submissions, prioritizing programs that demonstrated a clear understanding of the "whole child" philosophy.
- Phase III: Award Distribution (Early 2026): Funds will be disbursed to the selected recipients, allowing for the immediate implementation of support services.
- Phase IV: Impact Assessment: Throughout 2026 and into 2027, CureSearch will monitor the progress of these programs, collecting data on family engagement and patient outcomes to inform future grant cycles.
Implications for the Future of Pediatric Oncology
The expansion of the CCIA program signals a broader shift in the oncology landscape toward a more integrated model of care. As medical science continues to advance with the development of CAR-T cell therapies, precision medicine, and genomic sequencing, the human element of care becomes even more critical. High-tech treatments often require long hospital stays and complex follow-up care, which can exacerbate the psychosocial strain on families.
By investing in community impact, CureSearch is setting a precedent for how research-focused organizations can broaden their scope without losing sight of their primary mission. The 2026 awards acknowledge that a "cure" is not merely the absence of disease, but the restoration of a child’s ability to live a full, supported, and emotionally healthy life.
As the 2026 CCIA recipients begin their work, the ripple effects of these $15,000 grants are expected to be significant. In the world of pediatric cancer, where the stakes are life and death, the provision of a single support group or a specialized art therapy session can be the difference between a family that breaks under the pressure and one that finds the resilience to move forward. Through the combined power of cutting-edge research and compassionate community support, CureSearch continues to lead the way in transforming the future of childhood cancer care.

